Published in:
Open Access
01-11-2010 | Poster presentation
Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
Authors:
R Martínez, A Muñoz, M L Velloso, S Rodríguez Montero, M A Belmonte-López, J L Marenco
Published in:
Journal of Translational Medicine
|
Special Issue 1/2010
Login to get access
Excerpt
Rituximab (RTX) is an alternative for refractory patients with renal SLE, as several open studies support but the only randomized study did not find differences with immunosuppressives. Our objective is to know if RTX is effective for lupus nephritis refractory to immunosuppressive therapy. …